Crossject
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®. ZENEO® is no less than 12 years of R&D and more than 400 obtained patents. Currently, 8 treatments are in advanced stages of development, which 7 for emergency situations. With its unique know-how, Crossject aims to become a world leader in the self-administration of emergency needle free injectables.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 07:30 |
Regulatory News Service
CROSSJECT avance sur le développement de ZEPIZURE® Junior, sa solution pour les…
|
French | 108.9 KB | |
| 2025-06-11 07:30 |
Regulatory News Service
CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epi…
|
English | 110.5 KB | |
| 2025-06-06 17:45 |
Declaration of Voting Results & Voting Rights Announcements
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 152.9 KB | |
| 2025-06-04 20:21 |
Inside Information Statement
Lancement d’une augmentation de capital avec maintien du droit préférentiel de …
|
French | 292.3 KB | |
| 2025-06-04 20:21 |
Inside Information Statement
Launch of a capital increase with preferential subscription rights for nearly …
|
English | 216.7 KB | |
| 2025-06-03 07:30 |
Regulatory News Service
Maxim Group initie la couverture de l'action CROSSJECT avec une note à l’achat …
|
French | 100.9 KB | |
| 2025-06-03 07:30 |
Regulatory News Service
Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommenda…
|
English | 100.8 KB | |
| 2025-05-27 07:30 |
Regulatory News Service
CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘…
|
English | 111.6 KB | |
| 2025-05-27 07:30 |
Regulatory News Service
CROSSJECT met en place un nouveau module de fabrication pour augmenter la polyv…
|
French | 108.8 KB | |
| 2025-05-20 07:30 |
Capital/Financing Update
CROSSJECT prépare le lancement d’une augmentation de capital avec maintien du d…
|
French | 168.0 KB | |
| 2025-05-20 07:30 |
Capital/Financing Update
CROSSJECT prepares for the launch of a capital increase with preferential subs…
|
English | 275.8 KB | |
| 2025-05-15 07:30 |
Inside Information Statement
L'auto-injecteur sans aiguille ZENEO® de CROSSJECT est conforme aux profondeurs…
|
French | 147.5 KB | |
| 2025-05-15 07:30 |
Inside Information Statement
CROSSJECT’s ZENEO® needle-free autoinjector consistently matches depth of trad…
|
English | 148.5 KB | |
| 2025-05-07 07:30 |
Regulatory News Service
CROSSJECT provides updates on the EUA filing of ZEPIZURE®
|
English | 130.6 KB | |
| 2025-05-07 07:30 |
Regulatory News Service
CROSSJECT fait un point sur les dernières avancées dans le dépôt de la demande …
|
English | 130.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Alcon AG | Switzerland | ALC | |
|
Alteco Medical AB | Sweden | ALTE | |
|
Ambu | Denmark | AMBU | |
|
Arcoma AB | Sweden | ARCOMA | |
|
Asker Healthcare Group AB | Sweden | ASKER | |
|
Bactiguard Holding | Sweden | BACTI | |
|
BBS-Bioactive Bone Substitutes Oyj | Finland | BONE | |
|
BEACON ENERGY PLC | Isle of Man | BCE | |
|
BEBO Health S.A | Switzerland | MLBBO | |
|
BibbInstruments AB | Sweden | BIBB |